Book of Leviticus

BAPS Swaminarayan Akshardham, a Hindu Temple in New Jersey, Celebrates its Grand Opening as the World Looks On

Retrieved on: 
Wednesday, October 11, 2023
Public Policy, Government, Other Philanthropy, Architecture, Construction & Property, Religion, State, Local, Philanthropy, Consumer, Multimedia, Knowledge, Samuel Scheck Hillel Community Day School, Student, Community, Beth-El, Culture, World Interfaith Harmony Week, The Days, BAPS, Hindus, Festival, Education, Love, Swaminarayan, Volunteering, Day, Head, Learning, Woman, Book of Leviticus, Entertainment, Jewellery, Tourism, Akshardham

The monumental occasion was marked with an inauguration by His Holiness Mahant Swami Maharaj, the spiritual leader of BAPS.

Key Points: 
  • The monumental occasion was marked with an inauguration by His Holiness Mahant Swami Maharaj, the spiritual leader of BAPS.
  • View the full release here: https://www.businesswire.com/news/home/20231011365492/en/
    BAPS Swaminarayan Akshardham in Robbinsville, N.J. held its opening ceremony on October 8, 2023.
  • Several events were held in the week prior to Sunday’s grand opening, including programs that celebrated BAPS’ core values.
  • With a deep commitment to service, BAPS launched several community programs in anticipation of the grand opening of Akshardham.

Breakthrough in Device Therapy for Patients with Late-Stage Heart Disease

Retrieved on: 
Monday, January 10, 2022
VADS, Freedom, IKEM, Abdomen, NHS foundation trust, Heart failure, Book of Leviticus, Profile, Stroke, Development finance institution, TEL, Patient, Physician, Israel Innovation Authority, Quality of life, Thrombosis, Development Bank of Wales, Survival, Medical research, Center, Partnership, Future Fund, DizzyFIX, Elective surgery, CEO, Company, Newcastle upon Tyne Hospitals NHS Foundation Trust, VAD, LVAD, Catholic University of Leuven (1834–1968), Human, Innovation, Catholic higher education, FDA, Institute, Department, Infection, Mortality, Medical device, Pharmaceutical industry, Hospital, EU

Implantable heart pumps, known as Ventricular Assist Devices (or VADs), have proven to sustainably increase long term survival.

Key Points: 
  • Implantable heart pumps, known as Ventricular Assist Devices (or VADs), have proven to sustainably increase long term survival.
  • Together this FiVAD will significantly improve the lives of vast numbers of late-stage heart failure patients."
  • Leviticus Cardio is a medical device company dedicated to improving the clinical outcome for patients with an implanted left ventricular assist device (LVAD) for the treatment of impaired cardiac function.
  • The Leviticus FiVAD received several innovation awards, was implanted in humans in 2018/9 and received Breakthrough Device Designation from the FDA in 2019.

Honor Indigenous Americans this Thanksgiving with a new tradition

Retrieved on: 
Wednesday, November 24, 2021
People, Desolation Wilderness, Praise, Time, The Wall Street Journal, Citizen Potawatomi Nation, Wilde, Religion, Editorial, Lord, History, Matthew, Christianity, Anglo-French Wars, Israelites, Motivation, Book of Leviticus, Food, Essay, Change.org, Thanksgiving, Hunting, Salt

Randy Kritkausky, an author and enrolled tribal member of the Citizen Potawatomi Nation, says the passage is full of disdain for Indigenous people.

Key Points: 
  • Randy Kritkausky, an author and enrolled tribal member of the Citizen Potawatomi Nation, says the passage is full of disdain for Indigenous people.
  • He wants to provide families with an alternative reading as they gather for the 400th anniversary of Thanksgiving this year.
  • His essay, "Let's all say 'thanks' and then say 'sorry,'" acknowledges the harms done to Indigenous people, honors their historical contributions and wonders how we can make amends and move forward this Thanksgiving.
  • As we all know, the concept of a day of 'Thanksgiving' has a long history in America.

Pastor Robert Brashear joins Sim Shalom Online Synagogue on Yom Kippur

Retrieved on: 
Wednesday, September 25, 2019
Book of Leviticus, Yom Kippur, High Holy Days, Sim Shalom, Jewish culture, Hebrew language, Steven Blane

NEW YORK, Sept. 25, 2019 /PRNewswire-PRWeb/ -- Sim Shalom the Online Synagogue continues to provide innovative services for the Jewish High Holidays.

Key Points: 
  • NEW YORK, Sept. 25, 2019 /PRNewswire-PRWeb/ -- Sim Shalom the Online Synagogue continues to provide innovative services for the Jewish High Holidays.
  • This Yom Kippur, as in the past, Pastor Robert "Bob" Brashear will join Rabbi Steve Blane and his band and will offer a Yom Kippur sermon.
  • Typically Sim Shalom offers services each weeknight and Friday night online to its virtual community.
  • Sim Shalom is an interactive online Jewish Universalist synagogue which is liberal in thought and traditional in liturgy.

Statement by Minister Rodriguez on Yom Kippur

Retrieved on: 
Tuesday, September 18, 2018
Yom Kippur, Book of Leviticus, Jewish fast days, Jewish culture, Hebrew calendar, Human behavior, Yom, Multiculturalism in Canada, Atonement, Public holidays in Israel, Jewish holidays, Kol Nidre

Jewish communities in Canada and around the world observe Yom Kippur, the Day of Atonement

Key Points: 
  • Jewish communities in Canada and around the world observe Yom Kippur, the Day of Atonement
    OTTAWA, Sept. 18, 2018 /CNW/ -Today at sundown, Jewish communities across Canada and around the world will observe the beginning of Yom Kippur, the Day of Atonement.
  • On this solemn day, families and friends gather to pray and fast.
  • This year, as we mark the 30thanniversary of the Canadian Multiculturalism Act, Yom Kippur also gives us all a chance to highlight the contributions of the Jewish Canadians to our country.
  • As Minister of Canadian Heritage and Multiculturalism, Iextend my best wishes to everyone observing the holy day of YomKippur.

Leviticus Cardio Announces Successful Completion of Third Chronic Animal Study

Retrieved on: 
Friday, September 7, 2018
Medicine, Interventional cardiology, Cardiology, Medical devices, Circulatory system, Prosthetics, Ventricular assist device, Book of Leviticus, Jarvik, Heart

PETAH TIKVA, Israel, Sept.7, 2018 /PRNewswire/ -- Leviticus Cardio, inventors of the versatile transcutaneous Coplanar Energy Transfer (CET) system for use with implanted left ventricular assist devices (LVADs), announces the successful completion of a 90-day preclinical chronic animal study to evaluate its CET technology in combination with a commercial heart pump.

Key Points: 
  • PETAH TIKVA, Israel, Sept.7, 2018 /PRNewswire/ -- Leviticus Cardio, inventors of the versatile transcutaneous Coplanar Energy Transfer (CET) system for use with implanted left ventricular assist devices (LVADs), announces the successful completion of a 90-day preclinical chronic animal study to evaluate its CET technology in combination with a commercial heart pump.
  • The trial was conducted at a renowned animal facility operated by the Catholic University of Leuven, in Belgium.
  • This study marked the third successful trial of the Leviticus CET used in conjunction with a commercial heart pump.
  • "The successful completion of this third long-term chronic trial utilizing the Jarvik 2000 LVAD pump coupled with the Leviticus wireless CET system, demonstrates the desired versatility that addresses an increasing patient population suffering from advanced heart failure.

Leviticus Cardio Announces Successful Completion of Third Chronic Animal Study

Retrieved on: 
Thursday, September 6, 2018
Medicine, Interventional cardiology, Cardiology, Medical devices, Circulatory system, Prosthetics, Ventricular assist device, Book of Leviticus, Jarvik, Heart

PETAH TIKVA, Israel, Sept. 6 2018 /PRNewswire/ -- Leviticus Cardio, inventors of the versatile transcutaneous Coplanar Energy Transfer (CET) system for use with implanted left ventricular assist devices (LVADs), announces the successful completion of a 90-day preclinical chronic animal study to evaluate its CET technology in combination with a commercial heart pump.

Key Points: 
  • PETAH TIKVA, Israel, Sept. 6 2018 /PRNewswire/ -- Leviticus Cardio, inventors of the versatile transcutaneous Coplanar Energy Transfer (CET) system for use with implanted left ventricular assist devices (LVADs), announces the successful completion of a 90-day preclinical chronic animal study to evaluate its CET technology in combination with a commercial heart pump.
  • The trial was conducted at a renowned animal facility operated by the Catholic University of Leuven, in Belgium.
  • This study marked the third successful trial of the Leviticus CET used in conjunction with a commercial heart pump.
  • "The successful completion of this third long-term chronic trial utilizing the Jarvik 2000 LVAD pump coupled with the Leviticus wireless CET system, demonstrates the desired versatility that addresses an increasing patient population suffering from advanced heart failure.

Leviticus Cardio Announces Successful Animal Trial Demonstrating Wireless Power to Jarvik 2000

Retrieved on: 
Monday, June 18, 2018
Medicine, Cardiology, Interventional cardiology, Medical devices, Prosthetics, Ventricular assist device, Wireless, Book of Leviticus, Wireline, O. H. Frazier

PETAH TIKVA, Israel, June 18, 2018 /PRNewswire/ --Leviticus Cardio, inventor of wireless technology for certain medical devices,announces the successful animal implantation of the world's first Hybrid Wireless Fully Implanted Ventricular Assisted System or "Hybrid FILVAS.

Key Points: 
  • PETAH TIKVA, Israel, June 18, 2018 /PRNewswire/ --Leviticus Cardio, inventor of wireless technology for certain medical devices,announces the successful animal implantation of the world's first Hybrid Wireless Fully Implanted Ventricular Assisted System or "Hybrid FILVAS.
  • Leviticus, which has previously announced other successful wireless LVAD animal trials, conducted this trial with the Jarvik 2000.
  • Leviticus invented the versatile transcutaneous Coplanar Energy Transfer ("CET") system, which permits LVADs to be powered wirelessly.
  • We are proud to include the Jarvik 2000 among the pumps supported by Leviticus Cardio's wireless CET system and in this particular case, to demonstrate a new hybrid prototype for an implantedVAD to be powered by either wireless or wireline power."